CYCC Bio Green Med Solution Inc.


$ 1.46 $ 0.06 (4.29 %)    

Thursday, 13-Nov-2025 10:24:19 EST
QQQ $ 611.22 $ -6.46 (-1.05 %)
DIA $ 479.20 $ -2.17 (-0.45 %)
SPY $ 675.66 $ -4.79 (-0.71 %)
TLT $ 89.78 $ -0.02 (-0.02 %)
GLD $ 386.80 $ -0.48 (-0.12 %)
$ 1.44
$ 1.40
$ 1.43 x 330
$ 1.47 x 4
$ 1.44 - $ 1.46
$ 1.33 - $ 101.30
64,588
na
na
$ 1.30
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cyclacel-pharmaceuticals-exchanges-series-c-warrants-for-559395-common-shares-in-agreement-with-accredited-investors

On September 4, 2025, Cyclacel Pharmaceuticals, Inc. (the "Company") entered into a Warrant Exchange Agreement (the ...

 cyclacel-pharmaceuticals-stock-up-346-in-massive-after-hours-rally

After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 3...

 reported-earlier-cyclacel-announces-new-findings-supporting-use-of-plogosertib-in-biliary-tract-cancer-patients-with-high-bubr1-expression

  Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION